Key result
Directly infused low-dose streptokinase achieved patency in all 3 patients with axillary vein thrombosis without complications or marked systemic effects.
Why the study?
Does low-dose streptokinase infused directly into the involved vein improve patency in patients with axillary vein thrombosis?
Population
3 patients with venographically proven axillary vein thromboses (occluded from twelve hours to three weeks)
Design
Case_series
Authors
Loading...
Hypothesis-generating for direct low-dose streptokinase in axillary vein thrombosis; prospective trials needed before clinical adoption.
Case Report (n=3)
Does low-dose streptokinase infused directly into the involved vein improve patency in patients with axillary vein thrombosis?
Directly infused low-dose streptokinase successfully achieved vein patency in a small series of patients with axillary vein thrombosis without systemic complications.
Collier et al. (1984) conducted a case report in Axillary vein thrombosis (n=3). Low-dose streptokinase was evaluated on Patency. Directly infused low-dose streptokinase achieved patency in all 3 patients with axillary vein thrombosis without complications or marked systemic effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: